Fritextsökning
Artiklar per år
Innehållstyper
-
Cancerstudie stoppas i förtid
Lungcancerpatienter med dålig prognos överlevde signifikant längre tack vare en ny kombinationsbehandling. Nu avbryts studien som omfattat 1 157 patienter.
-
Hårt tryck på Läkemedelsverket
Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.